Matches in SemOpenAlex for { <https://semopenalex.org/work/W1947453148> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W1947453148 abstract "Aim: The aim of our study was to determine whether the ocular complications of onchocerciasis influenced the compliance with CDTI. Materials and methods: We conducted a cross-sectional descriptive study including all subjects aged 10 years or more. . The variables studied were visual acuity, type of visual impairment, gender, onchocerciasis ocular manifestations, the number of time Ivermectin was taken over the last 5 years. Results: We recruited 764 patients or 1528 eyes. The number of eyes with ocular manifestations of onchocerciasis was 56 while the number of eyes without was 1472. We found a prevalence of 48% good adherence CDTI within the general population. Nevertheless the prevalence among cases was of 57% good compliance compared to a prevalence of 48% among controls (P = 0.28). This similarity in the pattern of taking Ivermectin between female and male was found. Conclusion : Patients with onchocerciasis ocular involvement showed better compliance to CDTI in the Littoral region. Gender is not a factor influencing compliance to CDTI in our study in contrast to some available reports in the literature. The pattern of taking Ivermectin is not a contributing factor predisposing male to onchocerciasis ocular involvement. In the absence of visual impairment, patients with onchocerciasis ocular involvement have better compliance to CDTI. : The presence of onchocerciasis ocular involvement seems to be a motivating factor to a better compliance to CDTI for affected patients. Keywords: Compliance, Onchocerciasis, Ivermectin , Cameroon Normal 0 21 false false false FR JA X-NONE /* Style Definitions */ table.MsoNormalTable{mso-style-name:Tableau Normal;mso-tstyle-rowband-size:0;mso-tstyle-colband-size:0;mso-style-noshow:yes;mso-style-priority:99;mso-style-parent:;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-para-margin-top:0cm;mso-para-margin-right:0cm;mso-para-margin-bottom:10.0pt;mso-para-margin-left:0cm;line-height:115%;mso-pagination:widow-orphan;font-size:11.0pt;font-family:Calibri,sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-fareast-language:EN-US;}" @default.
- W1947453148 created "2016-06-24" @default.
- W1947453148 creator A5015337099 @default.
- W1947453148 creator A5016873631 @default.
- W1947453148 creator A5022570970 @default.
- W1947453148 creator A5073733688 @default.
- W1947453148 date "2014-04-25" @default.
- W1947453148 modified "2023-10-11" @default.
- W1947453148 title "Lésions oculaires de l’onchocercose et observance au Traitement à L’Ivermectine Sous Directives Communautaires (TIDC)." @default.
- W1947453148 cites W162358927 @default.
- W1947453148 cites W2000334503 @default.
- W1947453148 cites W2011497195 @default.
- W1947453148 cites W2046993421 @default.
- W1947453148 cites W2075563319 @default.
- W1947453148 cites W2110937228 @default.
- W1947453148 cites W2133227850 @default.
- W1947453148 hasPublicationYear "2014" @default.
- W1947453148 type Work @default.
- W1947453148 sameAs 1947453148 @default.
- W1947453148 citedByCount "1" @default.
- W1947453148 countsByYear W19474531482021 @default.
- W1947453148 crossrefType "journal-article" @default.
- W1947453148 hasAuthorship W1947453148A5015337099 @default.
- W1947453148 hasAuthorship W1947453148A5016873631 @default.
- W1947453148 hasAuthorship W1947453148A5022570970 @default.
- W1947453148 hasAuthorship W1947453148A5073733688 @default.
- W1947453148 hasConcept C119767625 @default.
- W1947453148 hasConcept C187212893 @default.
- W1947453148 hasConcept C203014093 @default.
- W1947453148 hasConcept C2777499811 @default.
- W1947453148 hasConcept C2780727990 @default.
- W1947453148 hasConcept C2780929884 @default.
- W1947453148 hasConcept C2908647359 @default.
- W1947453148 hasConcept C42972112 @default.
- W1947453148 hasConcept C71924100 @default.
- W1947453148 hasConcept C99454951 @default.
- W1947453148 hasConceptScore W1947453148C119767625 @default.
- W1947453148 hasConceptScore W1947453148C187212893 @default.
- W1947453148 hasConceptScore W1947453148C203014093 @default.
- W1947453148 hasConceptScore W1947453148C2777499811 @default.
- W1947453148 hasConceptScore W1947453148C2780727990 @default.
- W1947453148 hasConceptScore W1947453148C2780929884 @default.
- W1947453148 hasConceptScore W1947453148C2908647359 @default.
- W1947453148 hasConceptScore W1947453148C42972112 @default.
- W1947453148 hasConceptScore W1947453148C71924100 @default.
- W1947453148 hasConceptScore W1947453148C99454951 @default.
- W1947453148 hasIssue "2" @default.
- W1947453148 hasLocation W19474531481 @default.
- W1947453148 hasOpenAccess W1947453148 @default.
- W1947453148 hasPrimaryLocation W19474531481 @default.
- W1947453148 hasVolume "15" @default.
- W1947453148 isParatext "false" @default.
- W1947453148 isRetracted "false" @default.
- W1947453148 magId "1947453148" @default.
- W1947453148 workType "article" @default.